Page 11 of 60 Description This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-03. This solicitation is for a Small Business Set-Aside in the Open Market. The associated North American Industrial Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 1,250 Employees. The FSC/PSC is 6525. The Lexington VAMC is seeking the below items. All interested companies shall provide a quotation for the following: B.2 PRICE/COST SCHEDULE ITEM INFORMATION ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT 0001 40.00 EA __________________ __________________ F18-FLORBETAPIR NEURACEQ PER UNIT DOSE Contract Period: POP Begin: 03-15-2025 POP End: 03-14-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6525 - Imaging Equipment and Supplies: Medical, Dental, Veterinary LOCAL STOCK NUMBER: CLIN 0001 1001 55.00 EA __________________ __________________ F18-FLORBETAPIR NEURACEQ PER UNIT DOSE Contract Period: POP Begin: 03-15-2026 POP End: 03-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6525 - Imaging Equipment and Supplies: Medical, Dental, Veterinary LOCAL STOCK NUMBER: CLIN 0001 2001 70.00 EA __________________ __________________ F18-FLORBETAPIR NEURACEQ PER UNIT DOSE Contract Period: POP Begin: 03-15-2027 POP End: 03-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6525 - Imaging Equipment and Supplies: Medical, Dental, Veterinary LOCAL STOCK NUMBER: CLIN 0001 3001 85.00 EA __________________ __________________ F18-FLORBETAPIR NEURACEQ PER UNIT DOSE Contract Period: POP Begin: 03-15-2028 POP End: 03-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6525 - Imaging Equipment and Supplies: Medical, Dental, Veterinary LOCAL STOCK NUMBER: CLIN 0001 4001 100.00 EA __________________ __________________ F18-FLORBETAPIR NEURACEQ PER UNIT DOSE Contract Period: POP Begin: 03-15-2029 POP End: 03-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6525 - Imaging Equipment and Supplies: Medical, Dental, Veterinary LOCAL STOCK NUMBER: CLIN 0001 GRAND TOTAL __________________ B.3 DELIVERY SCHEDULE ITEM NUMBER SHIPPING INFORMATION QUANTITY DELIVERY DATE ALL CLINS VA Medical Center Lexington 1101 Veterans Drive Lexington, KY 40502 03/15/2025-03/14/2030 36C24925Q0157 Page 1 of Page 28 of 59 Page 1 of Please see the attached Statement of work for Salient Characteristics and expectations for this procurement. The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html. The following solicitation provisions apply to this acquisition: FAR 52.212-1, Instructions to Offerors Commercial Products and Commercial Services (Mar2023) Addendum- All quoters shall submit the below items. Non-compliance to the below items with this requirement may result in disqualification of the quote. Only one quote. Quote shall be on offeror s company letterhead, in PDF format and emailed to Ayslin.Kennett@va.gov NLT 03/06/2025 at 10:00 AM CT. The solicitation number, 36C24925Q0157 must be referenced in the subject line. Product information brochure with specifications and user manual shall accompany quote. Offeror must submit certification that equipment meets the salient characteristics of listed above. Quote must reflect the Statement of Work in this solicitation. FAR 52.212-2, Evaluation Commercial Items (NOV2021) Award will be based upon a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of FAR 13. Comparative evaluation is the side by side pairwise comparison of quotes based on factors resulting in a Contracting Officer decision for the quote most favorable to the Government. The following are the decision factors: (1) Price (2) Technical or Quality The offerors ability to meet desired turnaround times as stated in the Statement of Work. (3) Past Performance references The award will be made to the response most advantageous to the Government. Responses should contain your best terms and conditions. 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY RE